Amarantus Bioscience Holdings Inc (AMBS)

[michelebucks]

By Jason Napodano, CFA. "We get ESS worth approximately $0.21 per share. Amarantus stock is at $0.08 per share. Add in MANF for rare eye diseases and the Amarantus pipeline is looking rather impressive. The company has built a group of assets specifically designed to provide shareholders with at least one major value-creating event every year over the next four years. Each of these potential events could provide significant positive return for shareholders. For this reason we continue to believe that Amarantus stock is a good buy at today’s price. The current market capitalization is roughly $75 million. We think it could be worth $150 to $200 million as some of these value-creating events below are realized."